The role of the Kimura–Takemoto standard classification in determining follow-up groups for the prevention of stomach cancer in residents of the Northwestern Federal District of Russia
- 29 December 2025
- journal article
- Published by ECO-Vector LLC (Publications) in HERALD of North-Western State Medical University named after I.I. Mechnikov
- Vol. 17 (4) , 70-76
Abstract
BACKGROUND: Precancerous changes in the gastric mucosa identified during morphological examination often have macroscopic equivalents on endoscopy. In a number of studies comparing endoscopic and morphological changes in atrophic gastritis, the authors emphasized the limitations of applying these data depending on the region. It is relevant to conduct a similar study regarding the population of the Northwestern Federal District of Russia. AIM: To assess the prevalence of histological stages of gastric mucosal atrophy in different types and stages according to the Kimura–Takemoto endoscopic classification in the population of the Northwestern Federal District of Russia. METHODS: In a single-center cohort study, medical records of patients who underwent outpatient videoesophagogastroduodenoscopy between 2020 and 2022 were analyzed, and cases of gastric mucosal atrophy of any type according to the Kimura–Takemoto classification (173 men and 189 women) were selected. Gastric biopsies were obtained from five standard sites in accordance with the modified Sydney System, followed by morphological verification of the atrophy stage according to the Operative Link on Gastritis Assessment (OLGA) system, and the type and extent of intestinal metaplasia were determined when detected. RESULTS: From 1,188 medical records, 362 cases of gastric mucosal atrophy were selected. Kimura–Takemoto type C1 atrophy was detected in 123 patients; however, upon histological examination of biopsies, only 3 (2.4%) of them were found to have severe atrophy, which is an indication for dispensary endoscopic follow-up according to the recommendations of the Russian Gastroenterological Association and the Russian Endoscopic Society. Type C2 was detected in 98 patients, of whom 12 (12.2%) were found to have indications for follow-up based on the results of morphological analysis. Type C3 changes were detected in 47 patients, 14 (29.8%) of whom required follow-up. Signs of severe atrophy of types O1, O2, and O3 were detected in 28, 18, and 48 patients, respectively. Of these, 14 (50.0%), 13 (72.2%), and 31 (64.6%), respectively, required follow-up according to morphological analysis data. CONCLUSIONS: Open-type endoscopic atrophy (O1–O3) according to the Kimura–Takemoto classification demonstrated high concordance with histological signs of severe atrophy and intestinal metaplasia, and in the majority of cases, patients required further endoscopic follow-up. In contrast, in endoscopically mild C1-type atrophy, there were no signs of severe atrophy. In cases of limited resources and the absence of visual signs of atypia, biopsy may not be performed in this category of patients in routine practice.Keywords
This publication has 17 references indexed in Scilit:
- Linked color imaging-based endoscopic grading of gastric intestinal metaplasia and histological gastritis staging in the assessment of gastric cancer riskScandinavian Journal of Gastroenterology, 2022
- AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert ReviewGastroenterology, 2021
- Endoscopic grading of gastric intestinal metaplasia on risk assessment for early gastric neoplasia: can we replace histology assessment also in the West?Gut, 2020
- AGA Clinical Practice Guidelines on Management of Gastric Intestinal MetaplasiaGastroenterology, 2019
- The 2019 WHO classification of tumours of the digestive systemHistopathology, 2019
- Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019Endoscopy, 2019
- Helicobacter pylori eradication cannot reduce the risk of gastric cancer in patients with intestinal metaplasia and dysplasia: evidence from a meta-analysisGastric Cancer, 2015
- Relationship between Endoscopic and Histologic Gastric Atrophy and Intestinal MetaplasiaHelicobacter, 2012
- Helicobacter pyloriInfection and the Risk of Gastric CarcinomaNew England Journal of Medicine, 1991
- An Endoscopic Recognition of the Atrophic Border and its Significance in Chronic GastritisEndoscopy, 1969